Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$261M |
| 2 |
Alibaba
BABA
|
+$233M |
| 3 |
Truist Financial
TFC
|
+$191M |
| 4 |
Microsoft
MSFT
|
+$160M |
| 5 |
Amazon
AMZN
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$415M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$186M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$73.8M |
| 4 |
Oracle
ORCL
|
+$25.8M |
| 5 |
CBLK
Carbon Black, Inc. Common Stock
CBLK
|
+$23.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 15.12% |
| 3 | Healthcare | 12.68% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Communication Services | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Lazard
LAZ
$4.26B
| $3.03M | ﹤0.01% |
75,883
+6,863
| +10% | +$259K |
|
|
ARR
1602
Armour Residential REIT
ARR
$2.33B
| $3.03M | ﹤0.01% |
33,897
+1,649
| +5% | +$141K |
|
|
TIVO
1603
DELISTED
Tivo Inc
TIVO
| $3.02M | ﹤0.01% |
356,125
-550
| -0.2% | -$4.35K |
|
1604
OFG Bancorp
OFG
$2.26B
| $3.02M | ﹤0.01% |
127,779
+7,510
| +6% | +$164K |
|
1605
Caleres
CAL
$479M
| $2.99M | ﹤0.01% |
126,004
+12,222
| +11% | +$276K |
|
|
TRQ
1606
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $2.99M | ﹤0.01% |
409,872
+61,771
| +18% | +$318K |
|
1607
Oil States International
OIS
$507M
| $2.99M | ﹤0.01% |
183,283
+14,061
| +8% | +$214K |
|
1608
Yelp
YELP
$1.46B
| $2.99M | ﹤0.01% |
85,837
+3,183
| +4% | +$108K |
|
1609
Hyatt Hotels
H
$16.4B
| $2.99M | ﹤0.01% |
33,319
+2,641
| +9% | +$206K |
|
1610
Tompkins Financial
TMP
$1.46B
| $2.99M | ﹤0.01% |
32,667
+1,533
| +5% | +$133K |
|
1611
First Hawaiian
FHB
$3.44B
| $2.98M | ﹤0.01% |
103,269
+22,477
| +28% | +$632K |
|
1612
Innoviva
INVA
$1.54B
| $2.98M | ﹤0.01% |
210,204
+27,818
| +15% | +$341K |
|
1613
Minerals Technologies
MTX
$2.34B
| $2.97M | ﹤0.01% |
51,609
+6,900
| +15% | +$371K |
|
1614
ePlus
PLUS
$2.54B
| $2.97M | ﹤0.01% |
70,406
+4,824
| +7% | +$197K |
|
|
GBT
1615
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.94M | ﹤0.01% |
37,040
+6,920
| +23% | +$410K |
|
1616
Zurn Elkay Water Solutions
ZWS
$8.82B
| $2.94M | ﹤0.01% |
186,740
+1,245
| +0.7% | +$17.9K |
|
1617
Interface
TILE
$2.01B
| $2.93M | ﹤0.01% |
176,429
+21,644
| +14% | +$348K |
|
1618
BellRing Brands
BRBR
$1.48B
| $2.92M | ﹤0.01% |
+137,453
| New | +$2.69M |
|
|
HTT
1619
High Templar Tech Ltd
HTT
$393M
| $2.91M | ﹤0.01% |
618,461
+615,729
| +22,538% | +$3.62M |
|
1620
Enanta Pharmaceuticals
ENTA
$387M
| $2.89M | ﹤0.01% |
46,745
+3,019
| +7% | +$187K |
|
|
SAGE
1621
DELISTED
Sage Therapeutics
SAGE
| $2.86M | ﹤0.01% |
39,581
+4,943
| +14% | +$608K |
|
1622
Chegg
CHGG
$115M
| $2.85M | ﹤0.01% |
75,222
+10,390
| +16% | +$364K |
|
|
IBKC
1623
DELISTED
IBERIABANK Corp
IBKC
| $2.85M | ﹤0.01% |
38,065
+248
| +0.7% | +$18.4K |
|
|
GMS
1624
DELISTED
GMS Inc
GMS
| $2.85M | ﹤0.01% |
105,073
+9,329
| +10% | +$274K |
|
|
SRCI
1625
DELISTED
SRC Energy Inc
SRCI
| $2.84M | ﹤0.01% |
689,865
+62,287
| +10% | +$237K |
|
Similar funds
Legal & General Group's Q4 2019 Portfolio in Review
As of Q4 2019, Legal & General Group held 3,425 positions worth $210B, up 11% from $190B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3.9%. Legal & General Group opened 77 new positions and exited 57, leaving the 3,425-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- Legal & General Group's largest Q4 2019 buy was iShares MSCI Emerging Markets ETF: 425,000 shares worth $19.1M.
- Legal & General Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $261M increase.
- Legal & General Group's biggest Q4 2019 reduction was Oracle, cutting an estimated $25.8M.
- Legal & General Group fully exited Celgene Corp in Q4 2019, selling an estimated $415M.
- Legal & General Group's ten largest holdings make up 18% of its $210B portfolio in Q4 2019.
- Legal & General Group opened 77 new positions and closed 57 in Q4 2019.
- Legal & General Group's portfolio value rose 11% quarter-over-quarter to $210B.
Based on Legal & General Group's 13F filing for Q4 2019, filed 13 Feb 2020.